Showing results (141-150 of 455) with videos related to
Sort By:
Pageof 46
Pharmacology Research & Perspectives|November 26, 2019
Identification of repurposable drugs with beneficial effects on glucose control in type 2 diabetes using machine learningGideon Koren, Galia Nordon, Kira Radinsky, et al.Pharmacology Research & Perspectives|May 4, 2018
Machine learning of big data in gaining insight into successful treatment of hypertensionGideon Koren, Galia Nordon, Kira Radinsky, et al.Clinical Drug Investigation|March 15, 2019
Chronic Use of β-Blockers and the Risk of Parkinson's DiseaseGideon Koren, Galia Norton, Kira Radinsky, et al.Harefuah|October 22, 2018
[CHANGE IN HEALTHCARE UTILIZATION FOLLOWING DOCUMENTARY TV PROGRAM ABOUT YOUNG BREAST CANCER PATIENTS]Yossi Kuchnir, Itzhak Zeidise, Clara Weil, et al.Israel Journal of Health Policy Research|November 27, 2015
Family history intake: a challenge to personalized approaches in health promotion and disease preventionRonit Endevelt, Iris Goren, Tal Sela, et al.Expert Review of Clinical Pharmacology|June 25, 2019
Clinical pharmacology of old ageGideon Koren, Galia Nordon, Kira Radinsky, et al.Science (New York, N.Y.)|February 24, 2022
Minimizing treatment-induced emergence of antibiotic resistance in bacterial infectionsMathew Stracy, Olga Snitser, Idan Yelin, et al.International Journal of Cardiology. Cardiovascular Risk and Prevention|January 27, 2025
Inflammatory bowel disease is associated with an increased risk of cardiovascular events in a sex and age-dependent manner: A historical cohort studyNoa Cohen-Heyman, Gabriel ChodickFuture Cardiology|November 10, 2025
The interaction between inflammatory bowel disease and cardiovascular disease: what we knowGabriel Chodick, Noa Cohen-HeymanEclinicalmedicine|December 1, 2021
Adolescent body mass index and changes in pre-pregnancy body mass index in relation to risk of gestational diabetesGabriel Chodick, Maayan Omer-Gilon, Estela Derazne, et al.Pageof 46